Separate marketing from evidence tiers
Catalog claims should be tied to explicit evidence tiers. Controlled outcomes, mechanistic signals, and observational references should not be blended into one claim tier.
This structure helps researchers evaluate evidence confidence quickly and consistently.
Standardize metadata fields
Define a consistent schema for peptide identity fields, lot references, and profile details. Variability in field shape causes avoidable procurement errors.
Catalog cards should summarize key fields while dossier pages provide deeper reference context.
Design for validation and updates
Methodology should include update cadence, archival standards, and clear ownership for data integrity checks.
Treat the catalog as an operational system that requires routine governance, not static copy.